Plaque attack by microglial PLCγ2

PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunity (Cambridge, Mass.) Mass.), 2023-09, Vol.56 (9), p.1985-1987
Hauptverfasser: Comer, Ashley L., Hammond, Timothy R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1987
container_issue 9
container_start_page 1985
container_title Immunity (Cambridge, Mass.)
container_volume 56
creator Comer, Ashley L.
Hammond, Timothy R.
description PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD. PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD.
doi_str_mv 10.1016/j.immuni.2023.08.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2864900166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1074761323003680</els_id><sourcerecordid>2864900166</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-73ee781afff10483be0680fa4040609c98555f47b173634b1a2dd483bce6b74a3</originalsourceid><addsrcrecordid>eNp9kM1KxDAUhYMoOI6-gYviyk3rzU-TdCPI4B8UnIWuQ5omkrGdjklHmOfyPXwmU-ra1T2Lcw7nfghdYigwYH6zKXzf77e-IEBoAbIATI7QAkMlcoYlHE9asFxwTE_RWYwbAMzKChboat3pz73N9Dhq85E1h6z3Jgzvndddtq5XP9_kHJ043UV78XeX6O3h_nX1lNcvj8-ruzo3RMoxF9RaIbF2zmFgkjYWuASnGTDgUJlKlmXpmGiwoJyyBmvStpPPWN4IpukSXc-9uzCkSXFUvY_Gdp3e2mEfFZGcVWk458nKZmuaGmOwTu2C73U4KAxqQqI2akaiJiQKpEpIUux2jtn0xpe3QUXj7dbY1gdrRtUO_v-CXy5UakE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2864900166</pqid></control><display><type>article</type><title>Plaque attack by microglial PLCγ2</title><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Comer, Ashley L. ; Hammond, Timothy R.</creator><creatorcontrib>Comer, Ashley L. ; Hammond, Timothy R.</creatorcontrib><description>PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD. PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD.</description><identifier>ISSN: 1074-7613</identifier><identifier>ISSN: 1097-4180</identifier><identifier>EISSN: 1097-4180</identifier><identifier>DOI: 10.1016/j.immuni.2023.08.012</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Immunity (Cambridge, Mass.), 2023-09, Vol.56 (9), p.1985-1987</ispartof><rights>2023 Elsevier Inc.</rights><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c288t-73ee781afff10483be0680fa4040609c98555f47b173634b1a2dd483bce6b74a3</cites><orcidid>0000-0002-7073-892X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1074761323003680$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Comer, Ashley L.</creatorcontrib><creatorcontrib>Hammond, Timothy R.</creatorcontrib><title>Plaque attack by microglial PLCγ2</title><title>Immunity (Cambridge, Mass.)</title><description>PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD. PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD.</description><issn>1074-7613</issn><issn>1097-4180</issn><issn>1097-4180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kM1KxDAUhYMoOI6-gYviyk3rzU-TdCPI4B8UnIWuQ5omkrGdjklHmOfyPXwmU-ra1T2Lcw7nfghdYigwYH6zKXzf77e-IEBoAbIATI7QAkMlcoYlHE9asFxwTE_RWYwbAMzKChboat3pz73N9Dhq85E1h6z3Jgzvndddtq5XP9_kHJ043UV78XeX6O3h_nX1lNcvj8-ruzo3RMoxF9RaIbF2zmFgkjYWuASnGTDgUJlKlmXpmGiwoJyyBmvStpPPWN4IpukSXc-9uzCkSXFUvY_Gdp3e2mEfFZGcVWk458nKZmuaGmOwTu2C73U4KAxqQqI2akaiJiQKpEpIUux2jtn0xpe3QUXj7dbY1gdrRtUO_v-CXy5UakE</recordid><startdate>20230912</startdate><enddate>20230912</enddate><creator>Comer, Ashley L.</creator><creator>Hammond, Timothy R.</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7073-892X</orcidid></search><sort><creationdate>20230912</creationdate><title>Plaque attack by microglial PLCγ2</title><author>Comer, Ashley L. ; Hammond, Timothy R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-73ee781afff10483be0680fa4040609c98555f47b173634b1a2dd483bce6b74a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Comer, Ashley L.</creatorcontrib><creatorcontrib>Hammond, Timothy R.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Immunity (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Comer, Ashley L.</au><au>Hammond, Timothy R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plaque attack by microglial PLCγ2</atitle><jtitle>Immunity (Cambridge, Mass.)</jtitle><date>2023-09-12</date><risdate>2023</risdate><volume>56</volume><issue>9</issue><spage>1985</spage><epage>1987</epage><pages>1985-1987</pages><issn>1074-7613</issn><issn>1097-4180</issn><eissn>1097-4180</eissn><abstract>PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD. PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.immuni.2023.08.012</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-7073-892X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1074-7613
ispartof Immunity (Cambridge, Mass.), 2023-09, Vol.56 (9), p.1985-1987
issn 1074-7613
1097-4180
1097-4180
language eng
recordid cdi_proquest_miscellaneous_2864900166
source Cell Press Free Archives; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
title Plaque attack by microglial PLCγ2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A30%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plaque%20attack%20by%20microglial%20PLC%CE%B32&rft.jtitle=Immunity%20(Cambridge,%20Mass.)&rft.au=Comer,%20Ashley%20L.&rft.date=2023-09-12&rft.volume=56&rft.issue=9&rft.spage=1985&rft.epage=1987&rft.pages=1985-1987&rft.issn=1074-7613&rft.eissn=1097-4180&rft_id=info:doi/10.1016/j.immuni.2023.08.012&rft_dat=%3Cproquest_cross%3E2864900166%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2864900166&rft_id=info:pmid/&rft_els_id=S1074761323003680&rfr_iscdi=true